ISPOR HTA Roundtable Photo

 

ISPOR's Commitment to Payer Engagement

Healthcare decision makers, especially those responsible for making coverage and reimbursement decisions for pharmaceuticals and other health technologies, play an integral role in healthcare systems. These stakeholders are collectively referred to as “payers” and include those who work for the public and private organizations at both the assessment level (health technology assessment – HTA) and at the level of those who ultimately decide whether a health technology is reimbursed and at what price. 

ISPOR has served the global payer audience since 2006 through its resources and offerings, including Health Technology Assessment (HTA) Roundtables, HTA Council, global conferences, HTA-related Good Practices Reports, and more. ISPOR’s Health Technology Assessment Central microsite provides a comprehensive repository of resources and tools to support HTA. The Society also held its first Payer Engagement Summit in 2020 that convened global thought leaders to discuss common issues and challenges faced by global payers. On-demand recordings of this Summit can be found below.

 

ISPOR Payer Engagement Summit 2020

ISPOR held its first Payer Engagement Summit in 2020. The Summit, entitled “Quality, Access, and Use of Real-World Data (RWD) by Payers: Where Are We Now? Where Do We Want to Be in the Future?,” explored how payers can incorporate RWD into their decision making. One of the biggest challenges payers face today is the impact of innovative, new therapies for diseases with unmet-needs, such as cancer and rare diseases. These novel, high-cost therapies—some that require only 1 or 2 doses—are straining healthcare system budgets, raising affordability and equity issues, and creating a great deal of uncertainty for payers. Payers are addressing this challenge through a variety of approaches, including coverage with evidence development and outcomes-based contracts. RWD is critical to ensuring the success of these agreements. Beyond its use in managed entry agreements, RWD also plays a critical role in augmenting the scientific evidence of medical technologies. The use of RWD can empower payers to make efficient decisions that can reduce wasteful spending, improve patient outcomes, and lead to more sustainable healthcare systems.

 

Additional Payer Engagement Initiatives

 

Health Technology Assessment Council

  • Provide a platform for regional ISPOR HTA Roundtables to share issues and recommendations
  • Provide guidance in the translation and use of outcomes studies as useful information in the health technology assessment and healthcare decision-making processes.
  • Address issues and concerns of decision makers globally.
  • Assist in the development and implementation of initiatives related to the use of outcomes research information by healthcare decision makers.

Health Technology Assessment Roundtables

ISPOR’s Health Technology Assessment Roundtables provide a platform to advance scientific methods; to facilitate information sharing about the current state of HTA, its development, and its role in optimizing healthcare decisions; and to bridge the gap between technology assessors, private and public payers, regulators, and patients to improve health globally. HTA Roundtables convene annually in Asia Pacific, Europe, Latin America, Middle East and Africa, and North America. The first roundtable was founded in North America in 2006 and was comprised of invited members of pharmacy and therapeutics (P&T) committees in the United States and Canada and expanded over time to the current regional formats.

Health Technology Assessment Central

ISPOR’s Health Technology Assessment Central microsite (HTACentral.org) is a comprehensive repository of resources and tools to support HTA, that helps bridge the gap between health economics and outcomes research (HEOR) and other disciplines that inform HTA and healthcare decisions.

 

Member Group

Joint HTAi - ISPOR Deliberative Processes for HTA Task Force

Resources

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×